162 related articles for article (PubMed ID: 3221908)
1. Treatment of mice with anti-asialo-GM1 antibody or poly-I:C: effects on metastasis dissociable from modulation of macrophage antitumor activity.
Riser BL; Laybourn KA; Varani J
Nat Immun Cell Growth Regul; 1988; 7(5-6):305-15. PubMed ID: 3221908
[TBL] [Abstract][Full Text] [Related]
2. The role of anti-asialo GM1 antibody-sensitive cells in the implementation of tumor-specific T cell-mediated immunity in vivo.
Yoshioka T; Sato S; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1986 Aug; 77(8):825-32. PubMed ID: 3093429
[TBL] [Abstract][Full Text] [Related]
3. Discrimination between macrophage-and NK-type tumoricidal activities via anti-asialo GM1 antibody.
Keller R; Bächi T; Okumura K
Exp Cell Biol; 1983; 51(3):158-64. PubMed ID: 6852344
[TBL] [Abstract][Full Text] [Related]
4. Inability of anti-asialo-GM1 and 2-chloroadenosine to abrogate maleic anhydride-divinyl ether-induced resistance against experimental murine lung carcinoma metastases.
Schultz RM; Tang JC; DeLong DC; Ades EW; Altom MG
Cancer Res; 1986 Nov; 46(11):5624-8. PubMed ID: 3756909
[TBL] [Abstract][Full Text] [Related]
5. Suppression of pulmonary tumour metastasis in mice by recombinant human interleukin-2: role of asialo GM1-positive cells.
Hinuma S; Naruo K; Ootsu K; Houkan T; Shiho O; Tsukamoto K
Immunology; 1987 Feb; 60(2):173-9. PubMed ID: 3493209
[TBL] [Abstract][Full Text] [Related]
6. Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities.
Stitz L; Baenziger J; Pircher H; Hengartner H; Zinkernagel RM
J Immunol; 1986 Jun; 136(12):4674-80. PubMed ID: 3486908
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo interaction between murine fibrosarcoma cells and natural killer cells.
Laybourn KA; Hiserodt JC; Abruzzo LV; Varani J
Cancer Res; 1986 Jul; 46(7):3407-12. PubMed ID: 2939945
[TBL] [Abstract][Full Text] [Related]
8. [Role of asialo GM 1 positive cells in the control of metastatic spread of tumor cells in mice].
Shibuya M; Saijo N; Ozaki A; Beppu Y; Shimizu E; Takizawa T; Hoshi A
Gan To Kagaku Ryoho; 1983 Aug; 10(8):1781-6. PubMed ID: 6882003
[TBL] [Abstract][Full Text] [Related]
9. The effects of polyinosinic:polycytidylic acid (pI:C) on the graft-vs-host (GVH) reaction. II. Increased NK-mediated rejection on C57BL/6 lymphocytes by (C57BL/6 X A)F1 mice.
Peres A; Nestel FP; Seemayer TA; Lapp WS
J Immunol; 1986 Dec; 137(11):3420-7. PubMed ID: 3537120
[TBL] [Abstract][Full Text] [Related]
10. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver.
Wiltrout RH; Herberman RB; Zhang SR; Chirigos MA; Ortaldo JR; Green KM; Talmadge JE
J Immunol; 1985 Jun; 134(6):4267-75. PubMed ID: 3989307
[TBL] [Abstract][Full Text] [Related]
11. Role of natural killer cells and macrophages in the nonspecific resistance to tumors in mice stimulated with SMANCS, a polymer-conjugated derivative of neocarzinostatin.
Suzuki F; Pollard RB; Uchimura S; Munakata T; Maeda H
Cancer Res; 1990 Jul; 50(13):3897-904. PubMed ID: 2141295
[TBL] [Abstract][Full Text] [Related]
12. Augmentation of the antimetastatic effect of anticoagulant drugs by immunostimulation in mice.
Gorelik E
Cancer Res; 1987 Feb; 47(3):809-15. PubMed ID: 3802083
[TBL] [Abstract][Full Text] [Related]
13. Combined therapy of mice bearing a lymphokine-activated killer-resistant tumor with recombinant interleukin 2 and an antitumor monoclonal antibody capable of inducing antibody-dependent cellular cytotoxicity.
Kawase I; Komuta K; Hara H; Inoue T; Hosoe S; Ikeda T; Shirasaka T; Yokota S; Tanio Y; Masuno T
Cancer Res; 1988 Mar; 48(5):1173-9. PubMed ID: 3257715
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment.
Hanna N; Schneider M
J Immunol; 1983 Feb; 130(2):974-80. PubMed ID: 6848604
[TBL] [Abstract][Full Text] [Related]
15. Synergistic defense system by cooperative natural effectors against metastasis of B16 melanoma cells in H-2-associated control: different behavior of H-2+ and H-2- cells in metastatic processes.
Kawano Y; Taniguchi K; Toshitani A; Nomoto K
J Immunol; 1986 Jun; 136(12):4729-34. PubMed ID: 3711664
[TBL] [Abstract][Full Text] [Related]
16. Influence of adoptively transferred thioglycollate-elicited peritoneal macrophages on metastasis formation in mice with depressed or stimulated NK activity.
Gorelik E; Wiltrout RH; Brunda MJ; Bere WE; Herberman RB
Clin Exp Metastasis; 1985; 3(2):111-23. PubMed ID: 4042460
[TBL] [Abstract][Full Text] [Related]
17. In vivo administration of anti-asialo-GM1 antibody enhances splenic clearance of Listeria monocytogenes.
Schultheis RJ; Kearns RJ
Nat Immun Cell Growth Regul; 1990; 9(6):376-86. PubMed ID: 2128370
[TBL] [Abstract][Full Text] [Related]
18. Flow cytometric analysis reveals the presence of asialo GM1 on the surface membrane of alloimmune cytotoxic T lymphocytes.
Suttles J; Schwarting GA; Stout RD
J Immunol; 1986 Mar; 136(5):1586-91. PubMed ID: 2936802
[TBL] [Abstract][Full Text] [Related]
19. In vivo treatment of mice and hamsters with antibodies to asialo GM1 increases morbidity and mortality to pulmonary influenza infection.
Stein-Streilein J; Guffee J
J Immunol; 1986 Feb; 136(4):1435-41. PubMed ID: 3944461
[TBL] [Abstract][Full Text] [Related]
20. The suppressive effect of anti-asialo GM1 antibody on low-dose streptozotocin-induced diabetes in CD-1 mice.
Maruyama T; Watanabe K; Yanagawa T; Kasatani T; Kasuga A; Shimada A; Takei I; Suzuki Y; Kataoka K; Saruta T
Diabetes Res; 1991 Apr; 16(4):171-5. PubMed ID: 1802483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
